Vibostolimab
Modify Date: 2025-11-26 16:00:02
Vibostolimab structure
|
Common Name | Vibostolimab | ||
|---|---|---|---|---|
| CAS Number | 2231305-30-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VibostolimabVibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research[1]. |
| Name | Vibostolimab |
|---|
| Description | Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Vibostolimab binds to TIGIT and blocks the interaction between TIGIT and its ligands (CD112 and CD155), activating T lymphocytes which help to destroy tumor cells[1]. |
| References |
| No Any Chemical & Physical Properties |